Elite Pharmaceuticals Inc (ELTP)

[Couch]

I agree that the main issue at the present is to have freed up shares for money to continue with R&D and trial expenses. This deal IMO does benefit the company and the shareholder above and beyond another LPC type deal or a RS at the present moment. IMO to do a RS now would be disastrous. To do, IMO, and I have always been clear on this matter - you only do a RS after you have inked a partnership and gotten your lead product approved (and possibly launched) and then do a RS.

Now in terms of those shares being used for a partnership.......those waters are likely more your territory - and I'd defer to your historical experience but I was thinking a partnership may entail some mix of cash, percentage of take on SequestOx and shares of Elite. Just a thought.

As far as the 20% increase/dividend Nasrat gets for this deal - my assumption is Nasrat gets compensated for decreasing the share count by 20%. Fair is fair but many may not see it this way.